NEWS & EVENTS
Please check back here often for updates and news related to the Company’s development and the advancement of its compounds.
Please check the Articles section for related materials and background information on the development of opioid analgesics and opiate addiction treatments.
Phoenix PharmaLabs has received a Technology Transfer Grant from the National Institutes of Health to evaluate its lead compound as a potential treatment for cocaine addiction. Dr. Larry Toll, our CTO, was recruited earlier this year by Florida Atlantic University to become the University's first recruit under the 21st Century [...]
Perhaps our pleas to lawmakers have had an impact. Please contact your local representatives so they can put some pressure to get this bill approved. The goal of this bill (S. 2260) is to expand, intensify, and coordinate fundamental, translational, and clinical research capabilities of the National Institutes of Health [...]